You must log in to view this page.

SAB Biotherapeutics Inc. – Underwriting Agreements

NASDAQ: SABS
Share price (11/6/26): $3.03
Market cap (11/6/26): $273 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Underwriting Agreements Filter

EX-1

from SCHEDULE 13G/A 1 page Joint Filing Agreement

12/34/56

EX-1.1

from 8-K 50 pages 19,324,677 Shares of Common Stock Pre-Funded Warrants to Purchase Up to 2,753,246 Shares of Common Stock SAB Biotherapeutics, Inc. Underwriting Agreement

12/34/56

EX-1.1

from S-3 50 pages Certain Identified Information Has Been Excluded From the Exhibit Because Disclosure of Such Information Would Constitute a Clearly Unwarranted Invasion of Personal Privacy. Redacted Information Is Marked With a [*****]. SAB Biotherapeutics, Inc. Shares of Common Stock (Par Value $0.0001 Per Share) Sales Agreement

12/34/56

EX-1

from SCHEDULE 13G 1 page Joint Filing Agreement

12/34/56

EX-1.1

from 8-K 42 pages SAB Biotherapeutics, Inc. Shares of Common Stock (Par Value $0.0001 Per Share) Controlled Equity Offeringsm Sales Agreement

12/34/56

EX-1.1

from 8-K 31 pages 10,000,000 Units Big Cypress Acquisition Corp. Underwriting Agreement

12/34/56

EX-1.1

from S-1/A 31 pages 10,000,000 Units Big Cypress Acquisition Corp. Underwriting Agreement

12/34/56

SAB Biotherapeutics Inc. – Underwriting Agreements Watch

Search in Documents

Key Exhibits

External Links

Underwriting Agreements Filter

SAB Biotherapeutics Inc. – Underwriting Agreements